scholarly article | Q13442814 |
P50 | author | Michael Wigler | Q6835334 |
Daniel Birnbaum | Q64516222 | ||
P2093 | author name string | J. Fogh | |
O. Fasano | |||
L. Edlund | |||
P2860 | cites work | Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells | Q24629185 |
Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
Journal of Molecular and Applied Genetics | Q27711592 | ||
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ | Q27860770 | ||
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Isolation and preliminary characterization of the transforming gene of a human neuroblastoma cell line | Q28265250 | ||
Structure and activation of the human N-ras gene | Q28270953 | ||
Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene | Q28275191 | ||
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene | Q28279136 | ||
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter | Q29614259 | ||
Construction of a colicin E1-R factor composite plasmid in vitro: means for amplification of deoxyribonucleic acid | Q33797267 | ||
Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin | Q33980315 | ||
Transformation of mammalian cells with genes from procaryotes and eucaryotes | Q34030262 | ||
The transfer and stable integration of the HSV thymidine kinase gene into mouse cells | Q34140619 | ||
A human cell line from a pleural effusion derived from a breast carcinoma | Q34207627 | ||
Human-tumor-derived cell lines contain common and different transforming genes | Q34245850 | ||
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene | Q34253422 | ||
Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus | Q34253429 | ||
T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes | Q34253435 | ||
Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1. | Q34254574 | ||
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15 | Q34255274 | ||
Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells | Q34277765 | ||
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. | Q34280682 | ||
Mechanism of activation of a human oncogene | Q34708285 | ||
Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. | Q34708404 | ||
Packaging recombinant DNA molecules into bacteriophage particles in vitro | Q35042775 | ||
Nucleotide sequence of the rightward operator of phage lambda | Q35074385 | ||
Generation of transforming viruses in cultures of chicken fibroblasts infected with an avian leukosis virus | Q35241487 | ||
Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells | Q35242577 | ||
Recombinant bacteriophages containing the integrated transforming provirus of Gardner--Arnstein feline sarcoma virus | Q35393224 | ||
Transforming activity of human tumor DNAs | Q35426142 | ||
Activation of related transforming genes in mouse and human mammary carcinomas | Q35469217 | ||
Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells | Q36293758 | ||
Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses | Q36299131 | ||
Ubiquitous, interspersed repeated sequences in mammalian genomes. | Q36359699 | ||
Isolation and localization of DNA segments from specific human chromosomes | Q36389671 | ||
Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency | Q36394103 | ||
Molecular cloning of the avian erythroblastosis virus genome and recovery of oncogenic virus by transfection of chicken cells | Q36507789 | ||
Molecular cloning and characterization of the chicken gene homologous to the transforming gene of rous sarcoma virus | Q36595551 | ||
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA | Q36926920 | ||
McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms) | Q36937986 | ||
Three human transforming genes are related to the viral ras oncogenes | Q37608532 | ||
New Method for Detecting Cellular Transforming Genes | Q42824470 | ||
Three different human tumor cell lines contain different oncogenes | Q43550250 | ||
Linkage and expression of foreign DNA in cultured animal cells | Q43705147 | ||
Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas | Q44193267 | ||
The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb | Q45012365 | ||
Substitution of 5′ helper virus sequences into non-rel portion of reticuloendotheliosis virus strain T suppresses transformation of chicken spleen cells | Q45798977 | ||
In Vivo Identification of the Transforming Gene Product of Simian Sarcoma Virus | Q45799415 | ||
Avian sarcoma virus Y73 genome sequence and structural similarity of its transforming gene product to that of Rous sarcoma virus | Q45800368 | ||
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA | Q45802663 | ||
Sequence and structure of the coding region of the human H-ras-1 gene from T24 bladder carcinoma cells | Q48401065 | ||
The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes | Q53570306 | ||
A cellular oncogene (c-Ki-ras) is amplified, overexpressed and located within karyotypic abnormalities in mouse adrenocortical tumour cells | Q57382481 | ||
Charon phages: safer derivatives of bacteriophage lambda for DNA cloning | Q67558978 | ||
The transformation of Escherichia coli with deoxyribonucleic acid isolated from bacteriophage lambda-dg | Q79029238 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | transfection | Q1429031 |
cell biology | Q7141 | ||
P304 | page(s) | 1695-1705 | |
P577 | publication date | 1984-09-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | New human transforming genes detected by a tumorigenicity assay | |
New Human Transforming Genes Detected by a Tumorigenicity Assay | |||
P478 | volume | 4 |
Q64083388 | A blast from the past: on the brain |
Q40560010 | A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene |
Q28282360 | A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences |
Q37733288 | A method for difference cloning: gene amplification following subtractive hybridization |
Q41546161 | A novel downstream regulatory element of the mouse H-2Kb class I major histocompatibility gene |
Q35206630 | Activated RET and ROS: two new driver mutations in lung adenocarcinoma |
Q37394556 | Activated protooncogenes in human lung tumors from smokers |
Q42803597 | Activation of c-Ki-ras coexists with c-myc amplification in cells from a nude mouse tumor induced by the human breast carcinoma cell line SW 613-S. |
Q40509662 | Activation of gef-h1, a guanine nucleotide exchange factor for RhoA, by DNA transfection |
Q38352393 | Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia |
Q40659427 | Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene |
Q55280438 | An anionic phthalocyanine decreases NRAS expression by breaking down its RNA G-quadruplex. |
Q38742816 | An in vivo screening system to identify tumorigenic genes |
Q41024253 | Biological consequences of a point mutation at codon 969 of the FMS gene |
Q43476643 | Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma |
Q24557904 | Characterization of ROS1 cDNA from a human glioblastoma cell line |
Q24299869 | Characterization of an activated human ros gene |
Q37687208 | Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors |
Q35830708 | Characterization of preneoplastic and neoplastic lesions in the rat pancreas. |
Q31147621 | Ciz1, Cip1 interacting zinc finger protein 1 binds the consensus DNA sequence ARYSR(0-2)YYAC. |
Q36424474 | Cloning and characterization of putative genes that specify sensitivity to neoplastic transformation by tumor promoters |
Q30449946 | Complex regulation of the muscle-specific contractile protein (troponin I) gene |
Q40389164 | Concurrent mutations in two different ras genes in acute myelocytic leukemias |
Q42798594 | Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers. |
Q33679478 | Deletion of transfected oncogenes from NIH 3T3 transformants by inhibitors of poly(ADP-ribose) polymerase |
Q42805696 | Detection of novel non-ras oncogenes in rat nasal squamous cell carcinomas. |
Q42798928 | Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas |
Q46296687 | Determination of subcutaneous tumor size in athymic (nude) mice |
Q36901535 | Development and analysis of a transformation-defective mutant of Harvey murine sarcoma tk virus and its gene product. |
Q30449971 | Differentiation, not determination, regulates muscle gene activation: transfection of troponin I genes into multipotential and muscle lineages of 10T1/2 cells |
Q45103587 | Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors. |
Q24630982 | Expression and rearrangement of the ROS1 gene in human glioblastoma cells |
Q36843544 | Expression of transfected mutant beta-actin genes: transitions toward the stable tumorigenic state |
Q42799323 | Frequency of H-ras mutations in human bladder cancer detected by direct sequencing |
Q37690563 | Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors |
Q24559956 | G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity |
Q57406127 | Genetic mapping of thet-complex region on mouse chromosome 17 including theHybrid sterility-1 gene |
Q40667379 | Growth factor requirements of oncogene-transformed NIH 3T3 and BALB/c 3T3 cells cultured in defined media |
Q36922411 | Growth factor-deprived BALB/c 3T3 murine fibroblasts can enter the S phase after induction of c-myc gene expression |
Q36783419 | H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system |
Q37725228 | Hamster cell line suitable for transfection assay of transforming genes |
Q57416222 | Hras1-selected, chromosome-mediated transformants vary in phenotypein vitro and tumorigenic potentialin vivo |
Q39668510 | Human cancer and cellular oncogenes |
Q36801773 | Human papillomavirus type 6b DNA required for initiation but not maintenance of transformation of C127 mouse cells |
Q36837790 | Human recipient cell for oncogene transfection studies |
Q70093895 | Hybrid oncogenes. A multi-purpose tool for studying multi-step processes |
Q28587627 | Identification and characterization of a functional murine FLT3 isoform produced by exon skipping |
Q41636890 | Identification of a transforming ras oncogene in an ultraviolet radiation-induced corneal tumor of Monodelphis domestica |
Q28236903 | Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor |
Q45010084 | Identification of human gene complementing ts AlS9 mouse L-cell defect in DNA replication following DNA-mediated gene transfer |
Q24564122 | Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display |
Q24628785 | Identification of the protein encoded by the human diffuse B-cell lymphoma (dbl) oncogene |
Q37094517 | Importance of oncogene research to the cancer clinician |
Q34631459 | Increased radiation-induced transformation in C3H/10T1/2 cells after transfer of an exogenous c-myc gene |
Q34449959 | Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function |
Q42814928 | Isolation of a new human oncogene from a diffuse B-cell lymphoma. |
Q34337884 | Isolation of a rearranged human transforming gene following transfection of Kaposi sarcoma DNA. |
Q33930248 | Localization of the mcf.2 transforming sequence to the X chromosome |
Q24604031 | Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential |
Q42813389 | Low-level transforming activity of an activated Ras gene under the control of a vaccinia virus p40 promoter is abrogated by truncation of the Ras cDNA. |
Q37529389 | Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer |
Q35616027 | Molecular cloning of an oncogene from a human hepatocellular carcinoma |
Q23909570 | Mutational activation of the MAP3K8 protooncogene in lung cancer |
Q37679677 | Mutations in c-Ki-ras oncogenes in diseased livers of winter flounder from Boston Harbor. |
Q36062011 | Nullisomic deletion of the mcf.2 transforming gene in two haemophilia B patients |
Q39505491 | Oncogene amplification in tumor cells. |
Q41157704 | Optimisation of conditions for detection of activated oncogenes by transfection of NIH 3T3 cells |
Q42799554 | Preparation of functional liposomes with peptide ligands and their binding to cell membranes |
Q40867771 | Protein tyrosine kinase growth factor receptors and their ligands in development, differentiation, and cancer |
Q34381096 | RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes |
Q37777990 | ROS receptor tyrosine kinase: a new potential target for anticancer drugs |
Q35032725 | Radiation and chemical activation of ras oncogenes in different mouse strains. |
Q30486899 | Recessive mechanisms of malignancy |
Q35983016 | Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes |
Q26853181 | Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease |
Q34844276 | Role of proto-oncogene activation in carcinogenesis |
Q42804851 | Simultaneous transfer of tumorigenic and metastatic phenotypes by transfection with genomic DNA from a human cutaneous squamous cell carcinoma |
Q30654440 | Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms |
Q43628154 | Spontaneous progression of hyperplastic outgrowths of the D1 lineage to mammary tumors: expression of mouse mammary tumor virus and cellular proto-oncogenes |
Q41763700 | Suppression of defective RAS1 and RAS2 functions in yeast by an adenylate cyclase activated by a single amino acid change |
Q33561391 | The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein |
Q35831236 | The AMeX method: a multipurpose tissue-processing and paraffin-embedding method. Extraction of protein and application to immunoblotting |
Q57787206 | The Meaning of Mas |
Q34696613 | The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. |
Q36681820 | The oncogenic potential of an activated Hox-2.4 homeobox gene in mouse fibroblasts |
Q41590342 | The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma |
Q24652908 | The predicted DBL oncogene product defines a distinct class of transforming proteins |
Q34660060 | The role of oncogenes in chemical carcinogenesis |
Q42573442 | Transformation and stimulation of DNA synthesis in NIH-3T3 cells are a titratable function of normal p21N-ras expression. |
Q42797780 | Transformed NIH 3T3 cells expressing human melanoma N-ras oncogene metastasize to lymph node in nude mice |
Q35597846 | Transforming activity of human papillomavirus type 16 DNA sequence in a cervical cancer |
Q35609257 | Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa |
Q67919350 | Transforming genes and chromosome aberrations in therapy-related leukemia and myelodysplastic syndrome |
Q39511011 | Transforming genes and target cells of murine spleen focus-forming viruses |
Q33560907 | Transforming genes in chronic myelogenous leukemia |
Q41083296 | Transient and locally restricted expression of the ros1 protooncogene during mouse development |
Q33601670 | Translational infidelity and human cancer: role of the PTI-1 oncogene |
Q37689870 | Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells |
Q36499560 | Use of gene transfer and a novel cosmid rescue strategy to isolate transforming sequences |
Q41094066 | Yeast mutants temperature-sensitive for growth after random mutagenesis of the chromosomal RAS2 gene and deletion of the RAS1 gene. |
Q24610620 | cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity |
Q24313468 | p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins |
Q36066726 | pmcf.2-11, a single copy clone from chromosomal region 12q12-q13.1 [D12S32] |
Q54354904 | raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes. |
Q35034123 | ras activation in human tumors and in animal model systems |
Q24296261 | vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells |
Search more.